Finance
Bravely Exploring New Pathways to Harness Future Energy: State Grid Changzhou Power Supply Company's Commitment to High-Quality Local Economic and Social Development
CHANGZHOU,China,Feb. 7,2025-- On February 5,theChangzhou Municipal Government convened the City Enterprise Development Conference,where State Grid Changzhou Power Supply Company was honored with the &
HICC Pet® Launches Pet Care Academy of Magic at Pet Show Hong Kong 2025
Transforming Pet Care into a Magical Adventure:HICC Pet® offers spa-like grooming and healthcare while educating pet owners on maintaining their pets\' wellness.
TRILLER PUTS CREATORS FIRST AS IT UNLEASHES THE FUTURE OF TECH, MUSIC & CULTURE WITH THE LATEST VERSION OF ITS APP
Powered by next-generation technology and with data privacy front and center,Triller is redefining the creator economy with new ways for brands and creators to own their content,connect with their fa
Argent BioPharma: A Hidden Gem traded Under $12M--Edison Group Report Assigned a $327M Valuation to Its Breakthrough Epilepsy Treatment
PERTH,Australia,Feb. 6,2025-- Argent BioPharma (ASX: RGT) (OTCQB: RGTLF),a clinical-stage biopharmaceutical company brings hope to epilepsy patients.
Yum China Reports Fourth Quarter Results and Increases Dividend by 50%
Fourth Quarter Operating Profit Grew 36% and OP Margin1 Expanded 140 Basis Points Sequential Improvement in Same-Store Sales Index and Eighth Consecutive Quarter of Same-Store Transaction Growth
$50M historic gift fuels scholarships in coastal and marine sciences at William & Mary's Batten School & VIMS
Alumnus provides largest scholarship gift in university\'s history; Investment in the next generation of scientists and leaders comes at a time of global crisis
Elegoo to Open Pre-Orders for Centauri Carbon on February 17, Bringing Reliable CoreXY 3D Printing
SHENZHEN,China,Feb. 6,2025-- Elegoo,a rapidly developing brand in global smart manufacturing,announces today on its website that pre-ordersfor the highly anticipated Centauri Carbon,the company\'sfir
Serplulimab Approved in the EU for First-Line Treatment of Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
Serplulimab is the world\'s first anti-PD-1 monoclonal antibody (mAb) approved for first-line treatment of ES-SCLC
I Peace establishes and offers low immunoreaction risk GMP iPS Cells
Three lines of GMP iPS Cells derived from type O female blood are now offeredas off-the-shelf product
GCCL Applauded by Frost & Sullivan for Ensuring Consistent, Reliable Clinical Trial Data in APAC
GCCL is committed to customer success,emphasizing quality control at every stage—from analysis consulting and sample processing to data management—ensuring efficient clinical trials and research an